| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/JCPT.12334 |
| P698 | PubMed publication ID | 26547265 |
| P50 | author | Rupal M Patel | Q86646366 |
| P2093 | author name string | Stanford T Shulman | |
| P2860 | cites work | Diagnosis, treatment, and long-term management of Kawasaki disease | Q28171298 |
| Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy | Q28184382 | ||
| A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate | Q28193666 | ||
| Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial | Q28196604 | ||
| Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease | Q28219020 | ||
| Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease | Q33798966 | ||
| Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease | Q33965914 | ||
| Kawasaki disease in infants less than one year of age. | Q34307315 | ||
| Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study | Q34314065 | ||
| Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients | Q34398833 | ||
| A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome | Q34580488 | ||
| Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin | Q34629248 | ||
| Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease | Q34743347 | ||
| Abnormal Liver Panel in Acute Kawasaki Disease | Q34985732 | ||
| Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. | Q36731339 | ||
| Resistance to intravenous immunoglobulin in children with Kawasaki disease | Q36854706 | ||
| Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease | Q37041194 | ||
| Kawasaki disease: novel insights into etiology and genetic susceptibility | Q37778388 | ||
| Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study | Q37815637 | ||
| Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series | Q40296227 | ||
| Gamma globulin re-treatment in Kawasaki disease | Q40711476 | ||
| Sequelae of Kawasaki disease in adolescents and young adults | Q41073965 | ||
| Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids | Q42557663 | ||
| Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. | Q50636248 | ||
| Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. | Q50958607 | ||
| Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. | Q50987631 | ||
| The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin | Q58478448 | ||
| Management of Kawasaki disease: corticosteroids revisited | Q58921960 | ||
| P433 | issue | 6 | |
| P921 | main subject | Kawasaki disease | Q265936 |
| P304 | page(s) | 620-625 | |
| P577 | publication date | 2015-11-07 | |
| P1433 | published in | Journal of Clinical Pharmacy and Therapeutics | Q15753553 |
| P1476 | title | Kawasaki disease: a comprehensive review of treatment options | |
| P478 | volume | 40 |
| Q40075965 | An Unexpected Fever Post Serogroup B Meningococcal Sepsis |
| Q38429932 | Differential protein analysis of serum exosomes post-intravenous immunoglobulin therapy in patients with Kawasaki disease |
| Q40091671 | Effect and Safety of TNF Inhibitors in Immunoglobulin-Resistant Kawasaki Disease: a Meta-analysis |
| Q37681879 | Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis |
| Q64882658 | Incomplete Refractory Kawasaki Disease in an Infant-A Case Report and a Review of the Literature. |
| Q48130791 | Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial |
| Q38945126 | Kawasaki disease: etiopathogenesis and novel treatment strategies |
| Q64075568 | Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease |
| Q38676515 | Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores |
| Q39646187 | Role of the PTEN/PI3K/VEGF pathway in the development of Kawasaki disease |
| Q28079006 | The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart |
| Q64249669 | Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases |
| Q95511655 | [Changes in peripheral blood T helper 9 cells and interleukin-9 in children in the acute stage of Kawasaki disease] |
Search more.